In communities with high rates of consanguinity and consequently high prevalence of recessive phenotypes, homozygosity mapping with SNP arrays is an effective approach for gene discovery. In 20 Palestinian kindreds with prelingual nonsyndromic hearing loss, we generated homozygosity profiles reflecting linkage to the phenotype. Family sizes ranged from small nuclear families with two affected children, one unaffected sibling, and parents to multigenerational kindreds with 12 affected relatives. By including unaffected parents and siblings and screening 250 K SNP arrays, even small nuclear families yielded informative profiles. In 14 families, we identified the allele responsible for hearing loss by screening a single candidate gene in the longest homozygous region. Novel alleles included missense, nonsense, and splice site mutations of CDH23, MYO7A, MYO15A, OTOF, PJVK, Pendrin/SLC26A4, TECTA, TMHS, and TMPRSS3, and a large genomic deletion of Otoancorin (OTOA). All point mutations were rare in the Palestinian population (zero carriers in 288 unrelated controls); the carrier frequency of the OTOA genomic deletion was 1%. In six families, we identified five genomic regions likely to harbor novel genes for human hearing loss on chromosomes 1p13.3 (DFNB82), 9p23-p21.2/p13.3-q21.13 (DFNB83), 12q14.3-q21.2 (DFNB84; two families), 14q23.1-q31.1, and 17p12-q11.2 (DFNB85).
INTRODUCTION
Recessively inherited phenotypes are common in the Palestinian population as the result of a high frequency of consanguineous marriages. 1, 2 Palestinian families expressing such traits have cooperated with research studies to identify the critical genes for many phenotypes. In particular, Palestinian families with nonsyndromic hearing loss (NSHL) have been a valuable genetic resource for the identification of genes essential for normal hearing. [3] [4] [5] [6] [7] [8] Homozygosity mapping with SNPs has proven an effective approach to the identification of these genes, because persons with a recessive phenotype and born of a consanguineous union are likely to be homozygous both for the causative mutation and for polymorphisms in the genomic region surrounding the mutation. In this study, we used high-density SNP arrays to genotype the DNA of 155 relatives from 20 consanguineous families with autosomal recessive NSHL. Deafness-associated homozygosity profiles revealed loci likely to harbor novel genes for NSHL in 6 families and homozygous mutations in known genes for NSHL in 14 families. In all families, the deafness-causing mutation was present in the longest homozygous segment of the deaf individuals' genomes.
MATERIALS AND METHODS Subjects
Subjects with prelingual bilateral hearing loss (n¼238) were ascertained through schools for deaf children in the West Bank: Eftah School for the Deaf in Bethlehem, Al Amad School for the Deaf in Hebron, and the Princess Basma Rehabilitation Center for Deaf Children in Jerusalem. In addition, families were referred to the Hereditary Research Laboratory at Bethlehem University from the clinic of Dr Wael Salhab and from the Dar Al-Kalima Audiology Clinic in Bethlehem by Mr Michael Rahil. Families were contacted and informed consent was obtained from parents with assent from older children. The project was approved by the Human Subjects Committee of Bethlehem University and by the Human Subjects Division of the University of Washington. Pedigrees were constructed with 80% of families reporting consanguineous marriages. Audiological exams were performed to exclude hearing loss attributed to infection or trauma and to evaluate the severity and laterality of the hearing loss. Additional ascertainment was carried out for the extended families of 20 probands reporting affected relatives (Figure 1 ). For these 20 kindreds, all family members willing to participate were enrolled (Supplementary Table 1 ). Complete physical, visual, and vestibular exams were carried out to exclude syndromic deafness. Population controls comprised 288 Palestinian adults with normal hearing and came from two sources: (i) persons attending West Bank clinics for preventive health services (n¼201) and (ii) Palestinian individuals CG20   CG4  C3   A2  A9  A1  A8   A3  A4  A5 A11 A6 A7   BI 5  BI 4   BG14  BG10  BG11  BG12   BG9   DE3 DE4 DE5 DE6 DE7   DE2   Jn17 Jn18 Jn19 Jn20 Jn21  IB5  DP4  DO6  DO2  DO4 DO5   CG15  CG6 CG7   CG3 CG14  CG16 CG8   CG1  CG2   Gn18  Gn12  Gn11  Gn10  Gn9  Gn3   BI 8  BI 7   DA2 DD1 DD2 DD6
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Excluding known Palestinian deafness alleles
Genomic DNA was prepared by salting out. 9 Genomic DNA from 238 probands and 58 additional deaf relatives from 20 extended families were fully sequenced for both exons of connexin 26, as described. 10 In addition, all individuals were tested for deafness-associated alleles previously identified in families of Palestinian origin: Otoancorin.1067A4T, SLC26A4.716T4A, SLC26A4.1001G4T, TMPRSS3.988delA, TRIOBP.1039C4T, TRIOBP.1741C4T, 8, 11 Otoferlin.2416 T4A, 3 TECTA.IVS9(+1)G4A, 4 Otoancorin.IVS12(+2)G4T, 5 the b-satellite insertion of TMPRSS3, 6 and Whirlin.2332C4T. 7 
Homozygosity mapping
Genomic DNA samples (250 ng) were hybridized on Affymetrix GeneChip (Santa Clara, CA, USA) Human Mapping 250K NspI arrays according to the manufacturer's protocol (http://www.affymetrix.com). Arrays were scanned using the Affymetrix Gene Chip Scanner 3000 with the Gene Chip Operating System 1.4 (GCOS). Data were analyzed using the Gene Chip DNA Analysis Software 2.0 (GDAS) and classified by chromosome and sorted on the basis of the physical position of the SNPs. Homozygous regions were defined as segments where SNPs were homozygous for one allele among affected relatives but discordant (heterozygous or homozygous of the complement allele) among unaffected relatives in the pedigree. Enhanced stringency requirements for SNP quality were applied, with only SNPs with a quality score better than 0.06 from GDAS and GCOS being retained, thus using about 67% of the SNPs in homozygosity analyses. A segment was considered continuously homozygous if there was no more than one heterozygous SNP in any 10-SNP window. Homozygous segments of 2 Mb or longer were retained for further analysis. LOD scores 12 were calculated for these homozygous segments for each family, exploiting genotypes of all informative SNPs. The LOD score for a family depends on the family's structure and parameters of the recessive model and is the same for all informative homozygous regions in the genome.
Sequencing known genes
Previously described deafness genes 13 mapping within homozygous regions greater than 2 Mb were evaluated by Sanger DNA sequencing of PCR amplicons. Primers were designed to encompass all annotated exons and 50-100 bp of flanking intronic sequence. 8 Primers for Cadherin23, ESRRB, Otoferlin, Pejvakin, Myosin 7A, Myosin 15A, SLC26A4, TECTA, TMC1, TMHS, and TMPRSS3 are available on request. For families C, AN, and CB, both genomic DNA and RNA from white cells were available; for the other families, only genomic DNA was available for analysis. As each new mutation was identified, the additional 218 deaf probands and 288 hearing controls were screened by PCR-RFLP and direct sequencing.
Analysis of copy number variation
DNA samples from affected individuals were PCR amplified with unique STSs from the nonduplicated portion of the Otoancorin gene, exons 1-19 (chr16: 21 597 336-21 647 927). Primers are available on request. Genomic boundaries of the deletion in family DO and in Palestinian controls were determined by highresolution arrayCGH on NimbleGen 2.1 million probe arrays. Genomic samples were analyzed 14 using NA15724 as the reference genome for hybridizations. In controls, genomic deletion was evaluated by SYBR Green real-time PCR. Briefly, 10 ng of genomic DNA was amplified with primer sets located in exon 6 of Otoancorin and in intron 12 of Albumin (which served as an endogenous control) on an Applied Biosystems (Foster City, CA, USA) 7300 Real-Time PCR Instrument. Samples were run in quadruplicate alongside a known 2-copy control and a known 1-copy carrier from family DO. Raw C t values were collected and the relative fold difference between test samples and controls was determined using the 2 ÀDDC t method. 15 Samples with a 0.5-fold decrease in signal at Otoancorin relative to the known two-copy sample were analyzed by arrayCGH to determine break points.
RESULTS
In this cohort of 286 families, hearing loss is attributed to connexin 26 mutations in 8% of families (23/286) and to other previously described alleles of Palestinian origin in 9% of families (25/286). From the families of the unresolved 238 probands, we selected 20 informative kindreds in which parents reported consanguineous marriages and patterns of hearing loss were consistent with recessive inheritance (Figure 1 ). From these 20 kindreds, 78 individuals with NSHL, 28 of their hearing siblings, and 49 parents enrolled in the project (Supplementary Table 1) .
Each participant provided a sample of whole blood from which DNA was extracted and genotyped on Affymetrix 250K SNP arrays. We generated homozygosity profiles specific to the deaf individuals in each family, defining a deafness-associated homozygous peak as a contiguous genomic region 42 Mb across which SNPs were homozygous for one allele among affected relatives but discordant (heterozygous or homozygous for the alternate allele) among unaffected parents or sibs. For nine families, a single homozygous peak was observed, in five families two peaks were observed, and in six families multiple peaks were observed (Figure 2) .
In 16 of the 20 families, the longest homozygous region included a gene known to be associated with hearing loss (Table 1) . For each family, the relevant gene was fully sequenced from genomic DNA of the proband, revealing in 14 families alleles that were very likely to be deleterious. These included premature truncating alleles of Pejvakin, TECTA, TMPRSS3, and Otoferlin, a splice site mutation leading to a large in-frame deletion of the Pendrin/SLC26A4 message, and nonsynonymous mutations in MYO15A, MYO7A, CDH23, and TMHS, which were further evaluated by splicing analysis and molecular modeling. Detailed analyses of these point mutations are presented in Supplementary Information. One family (DO) harbored a large genomic deletion of Otoancorin. For three families (DE, BG, C), homozygous regions harbored known deafness genes, but full sequence analysis of these candidate genes did not reveal any rare alleles segregating with hearing loss. These linkage regions likely harbor as yet undiscovered genes for hearing loss. Finally, in three other families (CG, DP, CN), hearing loss mapped to homozygous regions that did not include known genes for human hearing loss, thereby also likely reflecting new recessive deafness loci in the Palestinian population. In summary, six of the 20 families are likely to represent five novel genes for NSHL.
Homozygosity for a genomic deletion of Otoancorin at 16p12
The largest homozygous peak in family DO was a 5.4 Mb region of chromosome 16p12.1-p12.2, including the gene Otoancorin. The genomic sequence flanking Otoancorin has multiple clusters of high-identity segmental duplications, which likely gave rise to a deletion spanning the Otoancorin gene through the nonallelic homologous recombination (Figure 3) . 16 The largest Otoancorin isoform comprises 28 exons. Exons 1-19 map to a single location in the human genome, but exons 20-28 are located in a 68 kb region that is segmentally duplicated, at greater than 99% identity, at chr16: 22 464 054-22 532 760, approximately 820 kb centromeric of the original locus.
From the genomic DNA of DO2, DO3, DO4, and DO5 (all of whom are deaf), PCR amplification of Otoancorin exons 1-19 failed to produce a product (Figures 3a and b) . In contrast, amplification of these exons from genomic DNA of DO1 and DO6 yielded products of normal size. This pattern suggests that the deaf individuals are homozygous for a genomic deletion spanning these exons. DNA from the same individuals was further analyzed by high-density genome-wide arrayCGH, revealing a deletion of approximately 500 kb that completely deletes the Otoancorin gene (Figure 3c ). Deaf individuals in family DO were homozygous for the deletion and their parents heterozygous for the deletion. The deletion is flanked Palestinian families with NSHL H Shahin et al Figure 2 Genomic regions of homozygosity associated with hearing loss. Each colored bar represents a genomic region homozygous for the same haplotype in all deaf individuals in a family, and heterozygous or homozygous for the alternate allele among unaffected parents or siblings in the same family. Chromosome arms are indicated on X-axes; lengths in Mb of the homozygous regions are indicated on Y-axes. Green bars represent homozygous regions with a deleterious mutation in a known deafness gene, as indicated in Table 1 . Red bars represent homozygous regions likely to harbor novel deafness genes as indicated in Table 2 . Blue bars indicate other regions of homozygosity. The identity between these two loci is approximately 99.7%, suggesting that the nonallelic homologous recombination is the likely mechanism of deletion, as has been described for other genomic regions. 16 The deletion was observed as a heterozygote in 1.0% of unrelated Palestinian controls (3/288). A comparison of the arrayCGH intensity values suggests that the mutations in family DO and in the controls have the same genomic breakpoints (Figure 3c ).
Novel deafness loci
In six families, homozygosity mapping suggests that hearing loss is due to mutations in as-yet-unidentified genes. The six families represent five new loci (ie, two families map to the same region). We identified the critical regions of linkage, calculated LOD scores for each of the six families, and reserved DFNB loci (HUGO Gene Nomenclature Committee) for families with LOD scores greater than 3.0 ( Figure 3a) . The DFNB82 region overlaps the DFNB32 locus by 833 kb. 17 DFNB32 was described in a Tunisian family with profound congenital hearing loss; the critical gene is not yet known. In DNA from family CG, we sequenced the two genes in the region of overlap (VAV3 and SLC25A24), but found no novel variants segregating with NSHL. It is therefore likely that DFNB82 and DFNB32 reflect different genes for NSHL.
DFNB83. Hearing loss in family DE maps to two regions of chromosome 9: a 9p region of 16.5 Mb and a pericentromeric region of 28.5 Mb (excluding the unannotated 15 Mb gap at the centromere; supplementary Figure 3b ). The LOD score is 3.07. The chromosome 9 pericentromeric region includes the NSHL gene TMC1. 18 The 9p region includes the MTAP gene, which is disrupted by a de novo balanced translocation in a child with syndromic deafness. 19 We sequenced all exons and conserved intronic regions of TMC1 and MTAP in family DE, but did not identify novel variants segregating with deafness in either gene. The DFNA47 locus maps within the DFNB83 region at chr9:13 046 167-21 980 675. 20 The gene responsible for DFNA47 is not known. It is possible that mutations of the same gene will be responsible for recessive and dominant hearing loss.
DFNB84. Deaf individuals in families CN and DP have overlapping regions of homozygosity and identical haplotypes over a 12.5 Mb region of chromosome 12q (chr12: 74 498 486-86 977 739) with an LOD score of 3.45 (supplementary Figure 3c) . No genes for inherited hearing loss have been described in this genomic interval and it therefore represents a novel locus for recessive NSHL.
DFNB85. Family C is a large kindred with 42 individuals enrolled. Hearing loss in family C maps to an 11.1 Mb region of chromosome 17p12-q11.2 with an LOD score of 7.25 (supplementary Figure 3d) . MYO15A lies in this region and was therefore an excellent candidate for the NSHL gene in this family. However, full sequencing of MYO15A from genomic DNA and lymphoblast cDNA from homozygous affected persons and heterozygous obligate carrier relatives revealed no functional mutations. Furthermore, the two alleles of MYO15A were expressed at the same levels in lymphoblast cDNA from obligate carriers, as determined by the evaluation of cSNP rs854772 in exon 40. Although it is possible that MYO15A may harbor a cryptic Table 1 Genomic regions homozygous in deaf individuals revealing mutations in known genes for hearing loss Figure 3e) . This region includes the gene ESRRB responsible for DFNB35. 21 Full sequencing of ESRRB in genomic DNA from affected relatives and carriers did not reveal any novel variants in the coding region or flanking regulatory regions. We hope to recruit additional informative relatives from family BG in an effort to reduce the size of the homozygous interval. Sizes of linked regions exclude gaps at centromeres.
DISCUSSION
For the analysis of recessively inherited hearing loss in these consanguineous families, homozygosity mapping with high-density SNP arrays yielded highly informative homozygosity profiles. In 14 families, the critical mutation was identified by sequencing a single gene mapping within the largest homozygous region. Even in small families with few deaf individuals (eg, families AM and CB), each with multiple homozygous peaks, the critical allele was still identifiable by searching exclusively in the largest region. None of the ten newly described alleles explain a high proportion of hearing loss among Palestinian families. In the Palestinian hearing population, heterozygous carriers were observed for only one allele, the large genomic deletion of OTOA. This region of chromosome 16p12.2 represents a 'hot spot' for genomic deletion because of its location between two identical segmental duplications. This specific deletion and the reciprocal duplication have been observed in 0.5-1.0% of European controls. 16 It has recently been shown that Stereocilin (DFNB15) is also subject to genomic rearrangements mediated by segmental duplications at chromosome 15q15.3. A homozygous deletion of 90 kb, including STRC and four other genes, is responsible for a syndromic form of deafness with male infertility. 22, 23 The carrier frequency of the STRC deletion has been estimated at 1.6%. It is possible that homozygous deletions of OTOA and STRC will be enriched in deaf individuals from other consanguineous communities.
The six families in which NSHL maps to five new loci represent an excellent opportunity to identify novel genes essential for normal hearing. The genomic regions harboring these genes are large (generally 410 Mb), but the critical gene can be identified readily with next generation sequencing approaches. Consanguineous kindreds, even small families, prove extremely valuable for the identification of novel alleles and novel loci. Of the families evaluated in this project, 30% are likely to reveal additional genes for hearing loss. This proportion suggests that a large number of genes critical to hearing remain to be discovered.
